Literature DB >> 11770117

Current issues in the treatment of visceral leishmaniasis.

A Bryceson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11770117     DOI： 10.1007/s004300100086

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  3 in total

1.  Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds.

Authors:  M A Dea-Ayuela; S Rama-Iñiguez; J M Alunda; F Bolás-Fernandez
Journal:  Vet Res Commun       Date:  2007-01-19       Impact factor: 2.459

2.  Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.

Authors:  Karen M Grant; Morag H Dunion; Vanessa Yardley; Alexios-Leandros Skaltsounis; Doris Marko; Gerhard Eisenbrand; Simon L Croft; Laurent Meijer; Jeremy C Mottram
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  In Silico Insights into the Mechanism of Action of Epoxy-α-Lapachone and Epoxymethyl-Lawsone in Leishmania spp.

Authors:  Juliana Figueiredo Peixoto; Adriane da Silva Oliveira; Patrícia Queiroz Monteiro; Luiz Filipe Gonçalves-Oliveira; Valter Viana Andrade-Neto; Vitor Francisco Ferreira; Franklin Souza-Silva; Carlos Roberto Alves
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.